QA: Amneal Pharmaceuticals Inc in us_pharma/2025

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001723128_2026_Amneal_Pharmaceuticals_Inc.pdf

Logs

Graph

Absolute values for 0001723128, Amneal Pharmaceuticals Inc

  xvar xval
0 AssetsCurrent 1,911,181,000
1 IntangibleAssetsNetIncludingGoodwill 1,158,968,000
2 PropertyPlantAndEquipmentNet 442,950,000
3 remainder_Assets 165,181,000
4 LiabilitiesCurrent 881,633,000
5 LiabilitiesNoncurrent 2,790,684,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 1,956,818,561
8 SellingGeneralAndAdministrativeExpense 555,823,903
9 ResearchAndDevelopmentExpense 186,414,461
10 remainder_Expenses 23,926,658
11 remainder_Revenues 3,030,825,192
12 remainder_NetIncome -325,173,268
13 remainder_ComprehensiveNetIncome -96,190,545
  yvar yval
0 Assets 3,678,280,000
1 Liabilities 3,672,317,000
2 Expenses 2,722,983,583
3 Revenues 3,030,825,192
4 StockholdersEquity 5,963,000
5 NetIncome -17,331,659
6 ComprehensiveNetIncome -65,426,932
7 BaseVar 6,762,884,794
8 EconomicCapitalRatiobeforeLimitedLiability -0.0143
9 EconomicCapitalRatio 1.41

Edgar->Model Mapping

Feature Distribution

Change over Time